MIRA INFORM REPORT

 

 

Report No. :

344729

Report Date :

12.10.2015

           

IDENTIFICATION DETAILS

 

Name :

HOVID BERHAD

 

 

Formerly Known As :

HO YAN HOR (KAUSING BRAND) MEDICAL HALL SDN BHD

 

 

Registered Office :

121, Jalan Tunku Abdul Rahman, 30010 Ipoh, Perak

 

 

Country :

Malaysia

 

 

Financials (as on) :

30.06.2014

 

 

Date of Incorporation :

20.05.1980

 

 

Com. Reg. No.:

58476-A

 

 

Legal Form :

Public Limited Company

 

 

Line of Business :

Subject is engaged in Manufacturing of Pharmaceutical and Herbal Products.

 

 

No. of Employee :

500 [2015]

 


 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES:

Any query related to this report can be made on e-mail: infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

Malaysia

A2

A2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 


 

MALAYSIA - ECONOMIC OVERVIEW

 

Malaysia, a middle-income country, has transformed itself since the 1970s from a producer of raw materials into an emerging multi-sector economy. Under current Prime Minister NAJIB, Malaysia is attempting to achieve high-income status by 2020 and to move farther up the value-added production chain by attracting investments in Islamic finance, high technology industries, biotechnology, and services. NAJIB's Economic Transformation Program (ETP) is a series of projects and policy measures intended to accelerate the country's economic growth. The government has also taken steps to liberalize some services sub-sectors. The NAJIB administration also is continuing efforts to boost domestic demand and reduce the economy's dependence on exports. Nevertheless, exports - particularly of electronics, oil and gas, palm oil and rubber - remain a significant driver of the economy. As an oil and gas exporter, Malaysia has profited from higher world energy prices, although the rising cost of domestic gasoline and diesel fuel, combined with sustained budget deficits, has forced Kuala Lumpur to begin to address fiscal shortfalls, through initial reductions in energy and sugar subsidies and the announcement of the 2015 implementation of a 6% goods and services tax. Falling global oil prices in the second half of 2014 have shrunk Malaysia’s current account surplus and put downward pressure on the ringgit. The government is also trying to lessen its dependence on state oil producer Petronas. The oil and gas sector supplies about 32% of government revenue in 2013. Bank Negara Malaysia (central bank) maintains healthy foreign exchange reserves, and a well-developed regulatory regime has limited Malaysia's exposure to riskier financial instruments and the global financial crisis. Nevertheless, Malaysia could be vulnerable to a fall in commodity prices or a general slowdown in global economic activity because exports are a major component of GDP. In order to attract increased investment, NAJIB earlier raised possible revisions to the special economic and social preferences accorded to ethnic Malays under the New Economic Policy of 1970, but retreated in 2013 after he encountered significant opposition from Malay nationalists and other vested interests. In September 2013 NAJIB launched the new Bumiputra Economic Empowerment Program (BEEP), policies that favor and advance the economic condition of ethnic Malays. Malaysia is a member of the 12-nation Trans-Pacific Partnership free trade agreement negotiations and, with the nine other ASEAN members, will form the ASEAN Economic Community in 2015.

 

Source : CIA

 

EXECUTIVE SUMMARY

 

REGISTRATION NO.

:

58476-A

COMPANY NAME

:

HOVID BERHAD

FORMER NAME

:

HOVID SDN BHD (05/12/2003)
HO YAN HOR SDN BHD (24/03/1998)
HO YAN HOR PHARMACEUTICALS SDN BHD (21/04/1989)
HO YAN HOR (KAUSING BRAND) MEDICAL HALL SDN BHD (21/05/1984)

INCORPORATION DATE

:

20/05/1980

COMPANY STATUS

:

EXIST

LEGAL FORM

:

PUBLIC

LISTED STATUS

:

YES

LISTED DATE

:

05/04/2005

REGISTERED ADDRESS

:

121, JALAN TUNKU ABDUL RAHMAN, 30010 IPOH, PERAK, MALAYSIA.

BUSINESS ADDRESS

:

121, JALAN TUNKU ABDUL RAHMAN, 30010 IPOH, PERAK, MALAYSIA.

TEL.NO.

:

05-5060690

FAX.NO.

:

05-5061215

EMAIL

:

INFO@HOVID.COM

WEB SITE

:

WWW.HOVID.COM

CONTACT PERSON

:

DAVID HO SUE SAN ( MANAGING DIRECTOR )

INDUSTRY CODE

:

21

PRINCIPAL ACTIVITY

:

MANUFACTURING OF PHARMACEUTICAL AND HERBAL PRODUCTS

AUTHORISED CAPITAL

:

MYR 200,000,000.00 DIVIDED INTO
ORDINARY SHARE 2,000,000,000.00 OF MYR 0.10 EACH.

ISSUED AND PAID UP CAPITAL

:

MYR 76,662,890.10 DIVIDED INTO
ORDINARY SHARES 766,628,901 CASH OF MYR 0.10 EACH.

SALES

:

MYR 183,542,000 [2014]

NET WORTH

:

MYR 166,157,000 [2014]

STAFF STRENGTH

:

500 [2015]

BANKER (S)

:

OCBC BANK (MALAYSIA) BHD
RHB BANK BHD
UNITED OVERSEAS BANK (MALAYSIA) BHD

LITIGATION

:

CLEAR

DEFAULTER CHECK

:

CLEAR

FINANCIAL CONDITION

:

STRONG

PAYMENT

:

PROMPT

MANAGEMENT CAPABILITY

:

AVERAGE

COMMERCIAL RISK

:

LOW

CURRENCY EXPOSURE

:

MODERATE

GENERAL REPUTATION

:

GOOD

INDUSTRY OUTLOOK

:

AVERAGE GROWTH

 

HISTORY/ BACKGROUND

 

As a public limited company, the Subject must have at least one shareholder but there is no limit on the maximum number of shareholders. The Subject must have at least two directors. A public limited company is a separate legal entity from its shareholders. As a separate legal entity, the Subject is capable of owning assets, entering into contracts, suing or be sued by other companies. The liabilities of the shareholders are only up to the extent of the equity they have taken up and the creditors cannot claim on shareholders' personal assets even if the Subject is insolvent. The Subject is governed by the Companies Act,1965 and must file in its annual return, together with its financial statements with the Registrar of Companies. In Malaysia, all the companies seeking listing on the Bursa Malaysia (Malaysia Stock Exchange) must be public limited companies.

 

The Subject is principally engaged in the (as a / as an) manufacturing of pharmaceutical and herbal products.

 

The Subject was listed on the Main Board of Bursa Malaysia Securities Bhd on 05/04/2005

 

Share Capital History

 

Date

Authorised Shared Capital

Issue & Paid Up Capital

21/04/2015

MYR 200,000,000.00

MYR 76,662,890.10

23/09/2014

MYR 200,000,000.00

MYR 76,381,450.00

20/06/2014

MYR 200,000,000.00

MYR 76,380,700.00

18/04/2014

MYR 200,000,000.00

MYR 76,379,930.00

22/01/2014

MYR 200,000,000.00

MYR 76,229,930.00

18/12/2013

MYR 200,000,000.00

MYR 76,229,100.00

16/12/2013

MYR 200,000,000.00

MYR 76,208,000.00

15/11/2013

MYR 200,000,000.00

MYR 76,209,100.00

10/10/2012

MYR 200,000,000.00

MYR 76,208,000.00

 

The major shareholder(s) of the Subject are shown as follows :

 


Name

Address

IC/PP/Loc No

Shareholding

(%)

MR. HO SUE SAN @ DAVID HO SUE SAN +

51, JALAN CHIN HWA, CHATEAU GARDEN, 30250 IPOH, PERAK, MALAYSIA.

490920-08-5903 1391613

281,803,400.00

36.76

EB NOMINEES (TEMPATAN) SENDIRIAN BERHAD FOR PLEDGED SECURITIES ACCOUNT FOR HO SUE SAN @ DAVID HO SU

-

-

111,000,000.00

14.48

CIMB GROUP NOMINEES (TEMPATAN) SDN. BHD. FOR PLEDGED SECURITIES ACCOUNT FOR HO SUE SAN @ DAVID HO S

-

-

42,500,000.00

5.54

KUMPULAN WANG PERSARAAN DIPERBADANKAN

-

-

38,569,100.00

5.03

AFFIN HWANG NOMINEES (TEMPATAN) SDN. BHD. FOR PLEDGED SECURITIES ACCOUNT FOR HO SUE SAN @ DAVID HO

-

-

23,000,000.00

3.00

MR. LIONG KAM HON

32, HALA PERAJURIT 6, TAMAN PERAK, 31400 IPOH, PERAK, MALAYSIA.

460328-08-5165 1397410

7,495,360.00

0.98

HONG LEONG ASSURANCE BERHAD AS BENEFICIAL OWNER (UNITLINKED GF)

-

-

7,019,800.00

0.92

HSBC NOMINEES (TEMPATAN) SDN BHD EXEMPT AN FOR SKANDINAVISKA ENSKILDA BANKEN AB (SWEDISH CLIENTS)

-

-

6,957,700.00

0.91

CIMSEC NOMINEES (TEMPATAN) SDN BHD FOR BANK OF SINGAPORE LTD FOR CHONG MEE FAH @ FREDERICK CHONG

-

-

6,750,000.00

0.88

CIMSEC NOMINEES (TEMPATAN) SDN. BHD. FOR CIMB BANK FOR GOH SIN BONG (MP0081)

-

-

6,500,000.00

0.85

AMANHRAYA TRUSTEES BERHAD FOR MIDF AMANAH STRATEGIC FUND

-

-

6,260,000.00

0.82

GOLDEN FRESH SDN. BHD.

-

139091P

6,013,100.00

0.78

CITIGROUP NOMINEES (ASING) SDN. BHD.

-

263875D

5,658,300.00

0.74

MAYBANK SECURITIES NOMINEES (TEMPATAN) SDN. BHD.

MAYBANLIFE TOWER, DATARAN MAYBANK, LEVEL 5, 1, JALAN MAAROF, 59000 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

284597P

5,595,900.00

0.73

AMSEC NOMINEES (TEMPATAN) SDN. BHD. FOR AMBANK (M) BERHAD (HEDGING)

BANGUNAN AMBANK GROUP, 55, JALAN RAJA CHULAN, 15TH FLOOR, 50200 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

102918T

5,035,500.00

0.66

RHB NOMINEES (TEMPATAN) SDN. BHD.

MALAYSIA

259064V

4,955,700.00

0.65

KENANGA NOMINEES (TEMPATAN) SDN. BHD.

-

16778M

4,194,700.00

0.55

REMAINING SHAREHOLDERS

-

-

197,320,341.00

25.74

---------------

------

766,628,901.00

100.00

============

=====

+ Also Director

 

The Subject's interest in other companies (Subsidiaries/Associates) are shown as follow :



Local No

Country

Company

(%)

As At

71816T

MALAYSIA

HOVID PHARMACY SDN. BHD.

100.00

26/11/2014

457587X

MALAYSIA

HOVID MARKETING SDN. BHD.

100.00

26/11/2014

848992P

MALAYSIA

BEST PRACTICE INTERNATIONAL SDN. BHD.

100.00

26/11/2014

714299D

MALAYSIA

HOVID NUTRIWORLD SDN. BHD.

100.00

26/11/2014

804511M

MALAYSIA

HOVID RESEARCH SDN. BHD.

100.00

26/11/2014

 

 

 

DIRECTORS

 

DIRECTOR 1

 

Name Of Subject

:

MR. YUEN KAH HAY

Address

:

7, LORONG BATU UBAN 5, TAMAN CENTURY, 11700 GELUGOR, PULAU PINANG, MALAYSIA.

IC / PP No

:

4562843

New IC No

:

540101-07-5261

Date of Birth

:

01/01/1954

Nationality

:

MALAYSIAN

Date of Appointment

:

02/01/2014

 

DIRECTOR 2

 

Name Of Subject

:

Y.M. RAJA SHAMSUL KAMAL BIN R SHAHRUZZAMAN

Address

:

1, JALAN 4/6, 40000 SHAH ALAM, SELANGOR, MALAYSIA.

IC / PP No

:

6183860

New IC No

:

610313-10-6665

Date of Birth

:

13/03/1961

Nationality

:

MALAYSIAN

Date of Appointment

:

22/12/2004

 

DIRECTOR 3

 

Name Of Subject

:

MR. GOH TIAN HOCK

Address

:

15, DATARAN PERAJURIT 3, TAMAN KEMUNCAK, 31400 IPOH, PERAK, MALAYSIA.

IC / PP No

:

A0734434

New IC No

:

670428-10-6563

Date of Birth

:

28/04/1967

Nationality

:

MALAYSIAN

Date of Appointment

:

02/01/2014

 

DIRECTOR 4

 

Name Of Subject

:

MR. CHUAH CHAW TEO

Address

:

4, PERSIARAN 8, ARENA KEPAYANG PUTRA, FAIR PARK, 31400 IPOH, PERAK, MALAYSIA.

IC / PP No

:

4235455

New IC No

:

510828-08-5973

Date of Birth

:

28/08/1951

Nationality

:

MALAYSIAN

Date of Appointment

:

22/12/2004

 

DIRECTOR 5

 

Name Of Subject

:

MR. CHIAM TAU MENG

Address

:

4, JALAN SS20/9, DAMANSARA UTAMA, 47400 PETALING JAYA, SELANGOR, MALAYSIA.

IC / PP No

:

4507124

New IC No

:

531028-01-6163

Date of Birth

:

01/01/1970

Nationality

:

MALAYSIAN

Date of Appointment

:

07/04/2014

 

DIRECTOR 6

 

Name Of Subject

:

DATO' CHE MOHD ZIN BIN CHE AWANG

Address

:

65, JALAN SS3/53, TAMAN SUBANG, 47300 PETALING JAYA, SELANGOR, MALAYSIA.

IC / PP No

:

2760805

New IC No

:

490928-03-5169

Date of Birth

:

28/09/1949

Nationality

:

MALAYSIAN

Date of Appointment

:

01/03/2012

 

DIRECTOR 7

 

Name Of Subject

:

MR. HO SUE SAN @ DAVID HO SUE SAN

Address

:

51, JALAN CHIN HWA, CHATEAU GARDEN, 30250 IPOH, PERAK, MALAYSIA.

IC / PP No

:

1391613

New IC No

:

490920-08-5903

Date of Birth

:

20/09/1949

Nationality

:

MALAYSIAN



MANAGEMENT

 

 

1)

Name of Subject

:

DAVID HO SUE SAN

Position

:

MANAGING DIRECTOR

 

 

 

AUDITOR

 

Auditor

:

SJ GRANT THORNTON

Auditor' Address

:

SHERATON IMPERIAL COURT, JALAN SULTAN ISMAIL, LEVEL 11, 50250 KUALA LUMPUR, WILAYAH PERSEKUTUAN, MALAYSIA.

 

 


 

COMPANY SECRETARIES

 

1)

Company Secretary

:

MS. NG YUET SEAM

IC / PP No

:

A0930116

New IC No

:

671205-08-5392

Address

:

1, LORONG EVERGREEN, TAMAN BUNGA RAYA, 31650 IPOH, PERAK, MALAYSIA.

 

2)

Company Secretary

:

MR. GOH TIAN HOCK

IC / PP No

:

A0734434

New IC No

:

670428-10-6563

Address

:

15, DATARAN PERAJURIT 3, TAMAN KEMUNCAK, 31400 IPOH, PERAK, MALAYSIA.

 

 

 

BANKING


Banking relations are maintained principally with :

1)

Name

:

OCBC BANK (MALAYSIA) BHD

 

2)

Name

:

RHB BANK BHD

 

3)

Name

:

UNITED OVERSEAS BANK (MALAYSIA) BHD

 

 

 

ENCUMBRANCE (S)

 

Charge No

Creation Date

Charge Description

Chargee Name

Total Charge

Status

1

01/07/1987

N/A

OVERSEACHINESE BANKING COPRPORATION LIMITED

MYR 2,050,000.00

Satisfied

2

01/07/1987

N/A

OVERSEA CHINESE BANKING CORPORATION LTD

MYR 500,000.00

Satisfied

3

01/07/1987

N/A

OVERSEA CHINESE BANKING CORPORATION

MYR 500,000.00

Satisfied

4

14/07/1987

N/A

OVERSEA CHINESE FINANCE COMPANY BERHAD

MYR 500,000.00

Satisfied

5

27/03/1989

N/A

KWONG YIK BANK BERHAD

MYR 500,000.00

Satisfied

6

27/03/1989

N/A

KWONG YIK BANK BERHAD

MYR 4,500,000.00

Satisfied

7

23/04/1990

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 1,000,000.00

Satisfied

8

23/04/1990

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 540,000.00

Satisfied

9

12/05/1990

N/A

SOUTHERN BANK BHD

MYR 200,000.00

Satisfied

10

06/11/1990

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 500,000.00

Satisfied

12

07/03/1991

N/A

BANK PEMBANGUNAN MALAYSIA BERHAD

MYR 1,400,000.00

Satisfied

11

03/07/1991

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 720,000.00

Satisfied

13

12/09/1991

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 8,315,000.00

Satisfied

14

12/09/1991

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 7,900,000.00

Satisfied

15

12/09/1991

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 415,000.00

Satisfied

16

12/09/1991

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 7,900,000.00

Satisfied

17

12/09/1991

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 415,000.00

Satisfied

18

16/11/1991

N/A

SOUTHERN BANK BHD

MYR 200,000.00

Satisfied

19

16/11/1992

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 2,000,000.00

Satisfied

20

16/11/1992

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 2,000,000.00

Satisfied

21

16/11/1992

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 2,000,000.00

Satisfied

22

16/11/1992

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 2,000,000.00

Satisfied

23

22/02/1993

N/A

SOUTHERN BANK BHD

MYR 200,000.00

Satisfied

24

15/09/1993

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 1,900,000.00

Satisfied

25

15/09/1993

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 900,000.00

Satisfied

26

15/09/1993

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 1,000,000.00

Satisfied

27

15/09/1993

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 900,000.00

Satisfied

28

15/09/1993

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 1,000,000.00

Satisfied

29

18/07/1995

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 1,500,000.00

Satisfied

30

18/07/1995

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 1,500,000.00

Satisfied

31

18/07/1995

N/A

UNITED MALAYAN BANKING CORPORATION BERHAD

MYR 1,500,000.00

Satisfied

32

16/11/1996

N/A

SOUTHERN BANK BERHAD

MYR 2,416,000.00

Satisfied

33

15/01/2001

N/A

OCBC BANK MALAYSIA BERHAD

MYR 15,000,000.00

Unsatisfied

34

15/01/2001

N/A

OCBC BANK MALAYSIA BERHAD

MYR 3,000,000.00

Unsatisfied

36

31/12/2001

N/A

BANK PEMBANGUAN DAN INFRASTRUKTUR MALAYSIA BERHAD

MYR 3,000,000.00

Satisfied

35

10/01/2002

N/A

OCBC BANK MALAYSIA BERHAD

MYR 3,000,000.00

Satisfied

37

01/07/2002

N/A

OCBC BANK MALAYSIA BERHAD

MYR 200,000.00

Satisfied

38

21/01/2003

N/A

OCBC BANK MALAYSIA BERHAD

MYR 1,000,000.00

Satisfied

39

21/01/2003

N/A

OCBC BANK MALAYSIA BERHAD

MYR 2,000,000.00

Unsatisfied

40

21/01/2003

N/A

OCBC BANK MALAYSIA BERHAD

MYR 1,800,000.00

Unsatisfied

41

08/10/2004

N/A

RHB BANK BERHAD

MYR 4,800,000.00

Satisfied

42

14/03/2005

N/A

RHB BANK BERHAD

MYR 3,447,134.00

Satisfied

43

21/11/2007

N/A

HWANGDBS INVESTMENT BANK BERHAD

-

Satisfied

44

09/05/2008

N/A

UNITED OVERSEAS BANK (MALAYSIA) BHD

-

Unsatisfied

45

16/09/2008

N/A

MALAYAN BANKING BHD

MYR 13,360,000.00

Unsatisfied

46

30/10/2009

N/A

AFFIN INVESTMENT BANK BERHAD

MYR 20,000,000.00

Satisfied

 

 

LITIGATION CHECK AGAINST SUBJECT


* A check has been conducted in our databank againt the Subject whether the Subject has been involved in any litigation. Our databank consists of 99% of the wound up companies in Malaysia.

No legal action was found in our databank.

No winding up petition was found in our databank.

 

DEFAULTER CHECK AGAINST SUBJECT


* We have checked through the Subject in our defaulters' database which comprised of debtors that have been blacklisted by our customers and debtors that have been placed or assigned to us for collection.

No blacklisted record & debt collection case was found in our defaulters' databank.


 

PAYMENT RECORD

 

 

SOURCES OF RAW MATERIALS:

 

Local

:

YES

Percentage

:

30%

Overseas

:

YES

Percentage

:

70%

Import Countries

:

CHINA,JAPAN,KOREA,GERMANY,INDIA,UNITED STATES


The Subject refused to provide any name of trade/service supplier and we are unable to conduct any trade enquiry. However, from financial historical data we conclude that :

 

OVERALL PAYMENT HABIT

Prompt 0-30 Days

[

X

]

Good 31-60 Days

[

]

Average 61-90 Days

[

]

Fair 91-120 Days

[

]

Poor >120 Days

[

]

 

 

CLIENTELE

 

Local

:

YES

Domestic Markets

:

MALAYSIA

Overseas

:

YES

Export Market

:

ASIA
EUROPE
MIDDLE EAST

Credit Term

:

AS AGREED

Payment Mode

:

CHEQUES
TELEGRAPHIC TRANSFER (TT)
LETTER OF CREDIT (LC)

Type of Customer

:

PHARMACEUTICAL INDUSTRIES,PHARMACIES,DEALERS,DISTRIBUTORS

 

 

OPERATIONS

 

Products manufactured

:

AMOXICLAR TABLET & GRANULES, GLOCOSAMINE, PREDISOLONE TABLET, TOCOTRIENOL (HEALTH SUPPLEMENT)

Product Brand Name

:

CONSAMINE , TOCOVID , PURI-SAFE , QUICKLEAN , GERMISEP , SUPRABIO , BETATON , DIABETMIN , ULTIMAX , EZEE ,NAGELESS , HO YAN HOR , HOVID , CHEWETTEC , AMOXICLAV , AMOXICAP , CLAMIDE , VIREST , FLUCOR , O YES ! ,NPREBIOLIN

Award

:

1 ) SPECIAL AWARD FOR INNOVATIVE PRODUCT BY MINISTRY OF INTERNATIONAL TRADE AND INDUSTRY (MITI) Year :2004

Member(s) / Affiliate(s)

:

FEDERATION OF MALAYSIAN MANUFACTURERS (FMM)

SMI ASSOCIATION OF MALAYSIA

MALAYSIA EXTERNAL TRADE DEVELOPMENT CORPORATION (MATRADE)

CHEMICAL INDUSTRIES COUNCIL OF MALAYSIA (CICM)

MALAYSIA FOOD & BEVERAGE INDUSTRY

Ownership of premises

:

OWNED

Shifts

:

2 SHIFTS (24 HOURS OPERATING)

 

Total Number of Employees:

 

YEAR

2015

2014

2013

2012

2011

GROUP

N/A

N/A

N/A

N/A

N/A

COMPANY

500

500

500

500

500

 

Branch

:

YES

 

Other Information:


The Subject is principally engaged in the (as a / as an) manufacturing of pharmaceutical and herbal products.

The Hovid Group's range of principal products and activities includes:

* special drug delivery systems, such as modified release formulations and bio-availability enhanced formulations;
* ethical products, including anti-biotics, anti-diabetics, anti-hypertensives, anti-malarial and anti-inflammatory analgesics;
* dietary supplements;
* consumer products; and
* the commercial extraction of palm tocotrienol complex, mixed carotenoid complex and phytosterols from palm fruits.

The Subject's manufacturing facilities and practices in respect of its pharmaceutical products conform to the PIC/S' GMP and Good Laboratory Practice Standards.

The Subject's herbal tea has been in the market since the early 40s and it comprises 26 types of herbs and is blended with tea leaves.

We were informed that the Subject has warehouses located in Kuala Lumpur, Pulau Pinang, Johor, Sabah and Sarawak.

The Group undertakes extraction and processing of nutrient from palm oil, trading of medical and pharmaceutical products.

The Group is also active in marketing health and wellness products via the multi-level network market.


 

 

RECENT DEVELOPMENT


19 February 2014

THE share price of Hovid Bhd, the country's largest publicly traded medical drug exporter in terms of sales, is on the verge of a major breakthrough.Hong Leong Industries Research, in a report, said on a technical platform, the stock's price has broken the "bullish flag" chart pattern. This was a result of strong buying interest since the start of the year, it added. According to the research house, the stock could move upwards and trade at between 39 sen and 40 sen a share. The stock currently trades in the 35 sen-a-share bandwagon.However, the technical parameters to value Hovid is much lower than CIMB Research's valuation of the company, based on its business.

To recap, CIMB Research last year valued Hovid at 43 sen a share but that valuation did not take into account the possibility of Hovid winning the United States Food and Drug Administration approval to sell tocotrienols as a drug.If successful, it could open up a market that is worth billions of ringgit in annual sales, CIMB had said in the report.More than half of Hovid's revenue is export-based and the company is the only Malaysia-listed pharmaceutical company that holds patents, signifying its strong research and development culture.

25th April 2012

The Sc, a manufacturer of ethical drugs and health and dietary supplements, plans to build a manufacturing plant in the Philippines, possibly within two years, as its business here improves, said its managing director David Ho.

The Philippine market had been generating steady sales for Hovid over the past seven years, Ho said.

He added that all of the company products, numbering almost 30, were well accepted in the country.

"We like to grow our products to more than 100 eventually and we are looking at setting up a plant here as imported products are subject to a three per cent here," he told Business Times on the sidelines of the Malaysia-Philippines Palm Oil Trade Fair & Seminar.

The seminar was organised by the Malaysian Palm Oil Council and the Malaysian Palm Oil Board.

There was also a forum themed "Healthy Lifestyle with Palm Products" targeting the medical fraternity within the Philippines.

Ho said SC products were managed and marketed by its wholly-owned subsidiary Hovid Philippines with a staff strength of more than 100 people.

"Business has been good for us here, although it took a while to get going as product registering takes about a year," he said.

Four to five per cent of SC revenue came from the Philippines, he added.

Close to 60 per cent of Hovid products are exported to most Asian countries, except Indonesia and Thailand, and African countries, which is its biggest market.

"We can not go into Indonesia because the country does not accept Malaysia-registered products while in Thailand, the product registering process is not easy and time-consuming," he lamented.

SC currently has two plants in Perak and one in India.

Ho said the company was looking at building another plant in Malaysia and it might take place next year.

He declined to reveal the likely investment cost but said even a small plant would cost between RM20 million and RM30 million.

On its business outlook this year, Ho said he was confident that Hovid would do well in the financial year ending June 30, 2012, after last financial year weak performance, in which it was dragged down by the numbers in its then loss-making subsidiary, Carotech Bhd.

For the second quarter ended December 31, 2011, SC net profit grew to RM10.76 million from RM1.47 million in the previous corresponding quarter.

It also made a one-time gain of RM7.7 million after it pared down its interest in Carotech to 17.6 per cent from 25 per cent previously.

 

CURRENT INVESTIGATION

Latest fresh investigations carried out on the Subject indicated that :

Telephone Number Provided By Client

:

N/A

Current Telephone Number

:

05-5060690

Match

:

N/A

Address Provided by Client

:

121, JALAN TUNKU ABDUL RAHMAN,30010,IPOH,PERAK.

Current Address

:

121, JALAN TUNKU ABDUL RAHMAN, 30010 IPOH, PERAK, MALAYSIA.

Match

:

YES

Latest Financial Accounts

:

YES

 

Other Investigations


We contacted one of the staff from the Subject and she provided some information.



FINANCIAL ANALYSIS

 

Profitability

Turnover

:

Increased

[

2010 - 2014

]

Profit/(Loss) Before Tax

:

Decreased

[

2010 - 2014

]

Return on Shareholder Funds

:

Acceptable

[

10.88%

]

Return on Net Assets

:

Acceptable

[

13.48%

]

The Subject's turnover increased steadily as the demand for its products / services increased due to the goodwill built up over the years.The dip in profit could be due to the stiff market competition which reduced the Subject's profit margin. The Subject's management had generated acceptable return for its shareholders using its assets.

Working Capital Control

Stock Ratio

:

Favourable

[

53 Days

]

Debtor Ratio

:

Acceptable

[

60 Days

]

Creditors Ratio

:

Favourable

[

24 Days

]

The Subject's stocks were moving fast thus reducing its holding cost. This had reduced funds being tied up in stocks. The Subject's management was quite efficient in handling its debtors. The Subject's debtors days were at an acceptable range, thus the risk of its debts turning bad was minimised. The Subject had a favourable creditors' ratio where the Subject could be taking advantage of the cash discounts and also wanting to maintain goodwill with its creditors.

Liquidity

Liquid Ratio

:

Favourable

[

2.45 Times

]

Current Ratio

:

Favourable

[

3.24 Times

]

A minimum liquid ratio of 1 should be maintained by the Subject in order to assure its creditors of its ability to meet short term obligations and the Subject was in a good liquidity position. Thus, we believe the Subject is able to meet all its short term obligations as and when they fall due.

Solvency

Interest Cover

:

Favourable

[

19.14 Times

]

Gearing Ratio

:

Favourable

[

0.04 Times

]

The interest cover showed that the Subject was able to service the interest. The favourable interest cover could indicate that the Subject was making enough profit to pay for the interest accrued. The Subject was lowly geared thus it had a low financial risk. The Subject was mainly financed by its shareholders' funds and internally generated funds. In times of economic slowdown / downturn, the Subject being a lowly geared company, will be able to compete better than those companies which are highly geared in the same industry.

Overall Assessment :

Although the Subject's turnover had increased, its profits had declined over the same corresponding period. This could be due to the stiffer market competition and / or higher operating costs which lowered the Subject's profit margin. The Subject was in good liquidity position with its total current liabilities well covered by its total current assets. With its current net assets, the Subject should be able to repay its short term obligations. With the favourable interest cover, the Subject could be able to service all the accrued interest without facing any difficulties. The Subject as a lowly geared company, will be more secured compared to those highly geared companies. It has the ability to meet all its long term obligations.

Overall financial condition of the Subject : STRONG

 

 

 

MALAYSIA ECONOMIC / INDUSTRY OUTLOOK

 

Major Economic Indicators:

2011

2012

2013

2014*

2015**

Population ( Million)

28.7

29.3

29.8

30.3

30.5

Gross Domestic Products ( % )

5.1

5.6

5.3

6.0

6.0

Domestic Demand ( % )

8.2

9.4

5.6

6.4

6.2

Private Expenditure ( % )

8.2

8.0

8.6

7.9

6.9

Consumption ( % )

7.1

1.0

5.7

6.5

5.6

Investment ( % )

12.2

11.7

13.3

12.0

10.7

Public Expenditure ( % )

8.4

13.3

4.4

2.3

4.2

Consumption ( % )

16.1

11.3

(1.2)

2.1

3.8

Investment ( % )

(0.3)

15.9

4.2

2.6

4.7

Balance of Trade ( MYR Million )

116,058

106,300

71,298

52,314

-

Government Finance ( MYR Million )

(45,511)

(42,297)

(39,993)

(37,291)

-

Government Finance to GDP / Fiscal Deficit ( % )

(5.4)

(4.5)

(4.0)

(3.5)

(3.0)

Inflation ( % Change in Composite CPI)

3.1

1.6

2.5

3.3

4.0

Unemployment Rate

3.3

3.2

3.0

3.0

3.0

Net International Reserves ( MYR Billion )

415

427

-

417

-

Average Risk-Weighted Capital Adequacy Ratio ( % )

3.50

2.20

-

-

-

Average 3 Months of Non-performing Loans ( % )

14.80

14.70

-

-

-

Average Base Lending Rate ( % )

6.60

6.53

6.53

-

-

Business Loans Disbursed( % )

15.3

32.2

-

-

-

Foreign Investment ( MYR Million )

23,546.1

26,230.4

38,238.0

-

-

Consumer Loans ( % )

-

-

-

-

-

Registration of New Companies ( No. )

45,455

45,441

46,321

-

-

Registration of New Companies ( % )

3.0

(0.0)

1.9

-

-

Liquidation of Companies ( No. )

132,485

17,092

26,430

-

-

Liquidation of Companies ( % )

417.8

(87.1)

54.6

-

-

Registration of New Business ( No. )

284,598

324,761

329,895

-

-

Registration of New Business ( % )

5.0

14.0

2.0

-

-

Business Dissolved ( No. )

20,121

20,380

18,161

-

-

Business Dissolved ( % )

1.9

1.3

(10.9)

-

-

Sales of New Passenger Cars (' 000 Unit )

535.1

552.2

576.7

598.4

610.3

Cellular Phone Subscribers ( Million )

35.3

38.5

43.0

43.8

-

Tourist Arrival ( Million Persons )

24.7

25.0

25.7

28.0

-

Hotel Occupancy Rate ( % )

60.6

62.4

62.6

-

-

Credit Cards Spending ( % )

15.6

12.6

-

-

-

Bad Cheque Offenders (No.)

32,627

26,982

28,876

-

-

Individual Bankruptcy ( No.)

19,167

19,575

21,984

-

-

Individual Bankruptcy ( % )

5.8

2.1

12.3

-

-



INDUSTRIES ( % of Growth ):

2011

2012

2013

2014*

2015**

Agriculture

5.8

1.0

2.1

3.8

3.1

Palm Oil

10.8

(0.3)

2.6

6.7

-

Rubber

6.1

(7.9)

(10.1)

(10.4)

-

Forestry & Logging

(7.6)

(4.5)

(7.8)

(4.2)

-

Fishing

2.1

4.3

1.6

2.7

-

Other Agriculture

7.1

6.4

8.2

6.2

-

Industry Non-Performing Loans ( MYR Million )

634.1

-

-

-

-

% of Industry Non-Performing Loans

3.2

-

-

-

-

Mining

(5.4)

1.4

0.9

(0.8)

2.8

Oil & Gas

(1.7)

-

-

-

-

Other Mining

-

-

-

-

-

Industry Non-performing Loans ( MYR Million )

46.5

-

-

-

-

% of Industry Non-performing Loans

0.1

-

-

-

-

Manufacturing #

4.7

4.8

3.4

6.6

5.5

Exported-oriented Industries

4.1

6.5

3.3

5.6

-

Electrical & Electronics

(4.0)

12.7

6.9

13.3

-

Rubber Products

20.7

3.0

11.7

(0.3)

-

Wood Products

(5.1)

8.7

(2.7)

5.1

-

Textiles & Apparel

13.2

(7.1)

(2.6)

11.5

-

Domestic-oriented Industries

10.7

1.7

6.8

9.4

-

Food, Beverages & Tobacco

4.80

2.70

3.60

6.13

6.13

Chemical & Chemical Products

10.0

10.8

5.6

-

-

Plastic Products

3.8

-

-

-

-

Iron & Steel

2.2

(6.6)

5.0

0.1

-

Fabricated Metal Products

21.8

13.8

9.9

2.9

-

Non-metallic Mineral

12.1

2.9

(2.0)

5.4

-

Transport Equipment

12.0

3.4

13.8

22.9

-

Paper & Paper Products

9.5

3.1

1.8

4.7

-

Crude Oil Refineries

9.3

-

-

-

-

Industry Non-Performing Loans ( MYR Million )

6,537.2

-

-

-

-

% of Industry Non-Performing Loans

25.7

-

-

-

-

Construction

4.7

18.6

10.9

12.7

10.7

Industry Non-Performing Loans ( MYR Million )

3,856.9

-

-

-

-

% of Industry Non-Performing Loans

10.2

-

-

-

-

Services

7.1

6.4

5.9

5.9

5.6

Electric, Gas & Water

3.5

4.4

4.2

3.6

3.9

Transport, Storage & Communication

6.50

7.10

7.30

7.50

7.15

Wholesale, Retail, Hotel & Restaurant

5.2

4.7

5.9

6.9

6.5

Finance, Insurance & Real Estate

6.90

9.70

3.70

4.65

4.25

Government Services

12.4

9.4

8.3

6.1

5.6

Other Services

5.1

3.9

5.1

4.8

4.5

Industry Non-Performing Loans ( MYR Million )

6,825.2

-

-

-

-

% of Industry Non-Performing Loans

23.4

-

-

-

-

* Estimate / Preliminary

** Forecast

# Based On Manufacturing Production Index

 

 

 

 

INDUSTRY ANALYSIS

 

MSIC CODE

21 : MANUFACTURE OF BASIC PHARMACEUTICALS, MEDICINAL CHEMICAL AND BOTANICAL PRODUCTS

INDUSTRY :

MANUFACTURING

The manufacturing sector is expected to grow by 5.5% in 2015. It will be bolstered by strong domestic and export-oriented industries in line with growing investment activities and favorable external demand. Moreover, in 2014, the manufacturing sectors have spearheading growth. The manufacturing sector is estimated to grow at a faster pace in 2014 on higher exports of electronics and electrical (E&E) products as external demand improves.

The manufacturing sector expanded strongly during the first half of 2014, the highest growth in three years, spurred by higher global semiconductor sales. Value-added of the manufacturing sector expanded 7.1% during the first half of 2014. Production of the sector rose 6.6% in the first seven months of 2014 supported by resilient domestic demand and recovery in the external sector during the first seven months of the years. The sales value of manufactured products rebounded by 7.7% in the first seven months of 2014. The strong performance of the sector was on account of higher output at 9.4% from the domestic-oriented industries, particularly transport equipment, food and beverage.

The manufacturing sector continued to attract domestic and foreign investment with investment approved by Malaysian Investment Development Authority (MIDA) totaling RM47.4 billion during the first six months of 2014, mainly from Japan, China and Germany. Meanwhile, the capacity utilization rate remained steady at 80.4% during the second quarter of 2014 while average wage per employee and productivity improved to RM2,772 per month and 5.9%, respectively during the first seven months of 2014. Boosted by favorable domestic economic activity and recovery in the external sector, the manufacturing sector is expected to record a better performance with growth of 6.4% in 2014.

In the meantime, production of wood products rebounded by 5.1% largely supported by higher output in the saw-milling and planning of wood segment at 25.9% during the first seven months of 2014. The positive performance was attributed to vibrant residential and commercial construction activities which contributed to increased use of timber frame and glued laminated timber for cost savings compared to the use of concrete and steel. Increased demand from major export destination such as the US, Japan and Australia for Malaysian made furniture contributed to the higher output, particularly wooden and cane furniture which rebounded by 2.2%.

Production of rubber products contracted 0.3% in the first seven months of 2014 on account of slower demand for rubber gloves and rubber tyres. The decline in rubber tyres for vehicles was due to the weaker external demand from the automotive industry, particularly from China. Output of other rubber products contracted 3.8% following the product shift from rubber-based to plastics, silicones and metal alloys in the manufacture of medical devices.

Besides, exports of manufactured products are expected to grow 6.1% in 2014 boosted by the growing demand from advanced economies. However, during the first seven months of 2014, manufactured exports surged 11.4%. The robust growth was buoyed by strengthening demand in the US and EU, reflecting significant exposure of Malaysian exports to the economic performance in the advance economies. The strength in export was broad-based with robust growth in both E&E and non- E&E subsectors.

Under budget 2015, the Government will provide incentive in the form of capital allowance on automation expenditure to encourage automation in the manufacturing sector, which may help in the manufacturing sector.

OVERALL INDUSTRY OUTLOOK : Average Growth

 

 

PROFIT AND LOSS ACCOUNT

 

THE FINANCIAL STATEMENTS WERE PREPARED IN ACCORDANCE WITH MALAYSIAN FINANCIAL REPORTING STANDARDS(FRS)

 

Financial Year End

2014-06-30

2013-06-30

2012-06-30

2011-06-30

2010-06-30

Months

12

12

12

12

12

Consolidated Account

GROUP

GROUP

GROUP

GROUP

GROUP

Audited Account

YES

YES

YES

YES

YES

Unqualified Auditor's Report (Clean Opinion)

YES

YES

YES

YES

YES

Financial Type

FULL

FULL

FULL

FULL

FULL

Currency

MYR

MYR

MYR

MYR

MYR

TURNOVER

183,542,000

172,510,000

164,808,000

153,456,000

365,166,000

Other Income

2,739,000

2,225,000

2,921,000

7,299,000

-

----------------

----------------

----------------

----------------

----------------

Total Turnover

186,281,000

174,735,000

167,729,000

160,755,000

365,166,000

----------------

----------------

----------------

----------------

----------------

PROFIT/(LOSS) FROM OPERATIONS

24,809,000

25,768,000

22,256,000

(2,172,000)

(97,678,000)

----------------

----------------

----------------

----------------

----------------

PROFIT/(LOSS) BEFORE TAXATION

24,809,000

25,768,000

22,256,000

(2,172,000)

(97,678,000)

Taxation

(6,507,000)

(5,888,000)

(6,498,000)

(3,945,000)

6,883,000

----------------

----------------

----------------

----------------

----------------

PROFIT/(LOSS) AFTER TAXATION

18,302,000

19,880,000

15,758,000

(6,117,000)

(90,795,000)

Minority interests

(218,000)

(146,000)

(76,000)

66,000

37,888,000

----------------

----------------

----------------

----------------

----------------

PROFIT/(LOSS) BEFORE EXTRAORDINARY ITEMS

18,084,000

19,734,000

15,682,000

(6,051,000)

(52,907,000)

Extraordinary items

-

-

-

12,088,000

-

----------------

----------------

----------------

----------------

----------------

PROFIT/(LOSS) ATTRIBUTABLE TO SHAREHOLDERS

18,084,000

19,734,000

15,682,000

6,037,000

(52,907,000)

RETAINED PROFIT/(LOSS) BROUGHT FORWARD

As previously reported

44,718,000

19,459,000

12,350,000

6,313,000

59,220,000

Prior year adjustment

-

145,000

-

-

-

----------------

----------------

----------------

----------------

----------------

As restated

44,718,000

19,604,000

12,350,000

6,313,000

59,220,000

----------------

----------------

----------------

----------------

----------------

PROFIT AVAILABLE FOR APPROPRIATIONS

62,802,000

39,338,000

28,032,000

12,350,000

6,313,000

TRANSFER TO RESERVES - General

(10,766,000)

5,380,000

-

-

-

DIVIDENDS - Ordinary (paid & proposed)

-

-

(8,573,000)

-

-

----------------

----------------

----------------

----------------

----------------

RETAINED PROFIT/(LOSS) CARRIED FORWARD

52,036,000

44,718,000

19,459,000

12,350,000

6,313,000

=============

=============

=============

=============

=============

INTEREST EXPENSE (as per notes to P&L)

Bank overdraft

235,000

574,000

810,000

900,000

2,496,000

Term loan / Borrowing

277,000

475,000

751,000

2,328,000

7,215,000

Others

856,000

1,320,000

1,632,000

3,323,000

7,801,000

----------------

----------------

----------------

----------------

----------------

1,368,000

2,369,000

3,193,000

6,551,000

17,512,000

=============

=============

=============

=============

=============

DEPRECIATION (as per notes to P&L)

5,440,000

5,320,000

5,188,000

7,831,000

22,520,000

AMORTIZATION

596,000

550,000

494,000

531,000

613,000

----------------

----------------

----------------

----------------

----------------

6,036,000

5,870,000

5,682,000

8,362,000

23,133,000

=============

=============

=============

=============

=============

 

 


BALANCE SHEET

 

HOVID BERHAD

 

ASSETS EMPLOYED:

FIXED ASSETS

98,415,000

111,555,000

91,054,000

91,618,000

396,991,000

Associated companies

-

-

-

14,033,000

-

Investment properties

2,400,000

2,000,000

1,680,000

850,000

850,000

Deferred assets

520,000

451,000

186,000

125,000

108,000

Others

-

-

-

-

269,000

----------------

----------------

----------------

----------------

----------------

TOTAL LONG TERM INVESTMENTS/OTHER ASSETS

2,920,000

2,451,000

1,866,000

15,008,000

1,227,000

Goodwill on consolidation

18,008,000

18,860,000

19,663,000

24,160,000

25,290,000

----------------

----------------

----------------

----------------

----------------

TOTAL INTANGIBLE ASSETS

18,008,000

18,860,000

19,663,000

24,160,000

25,290,000

----------------

----------------

----------------

----------------

----------------

TOTAL LONG TERM ASSETS

119,343,000

132,866,000

112,583,000

130,786,000

423,508,000

Stocks

26,494,000

26,337,000

29,543,000

23,688,000

83,162,000

Trade debtors

30,252,000

29,907,000

33,133,000

30,744,000

40,322,000

Other debtors, deposits & prepayments

10,228,000

7,765,000

11,710,000

6,495,000

7,485,000

Short term deposits

1,100,000

1,599,000

585,000

-

351,000

Deposits with financial institutions

-

-

-

897,000

-

Amount due from associated companies

-

-

-

516,000

-

Cash & bank balances

21,570,000

25,206,000

22,622,000

7,872,000

9,258,000

Others

18,725,000

-

-

-

-

----------------

----------------

----------------

----------------

----------------

TOTAL CURRENT ASSETS

108,369,000

90,814,000

97,593,000

70,212,000

140,578,000

----------------

----------------

----------------

----------------

----------------

TOTAL ASSET

227,712,000

223,680,000

210,176,000

200,998,000

564,086,000

=============

=============

=============

=============

=============

CURRENT LIABILITIES

Trade creditors

12,181,000

11,687,000

13,532,000

12,974,000

25,687,000

Other creditors & accruals

12,578,000

15,718,000

20,495,000

12,288,000

40,948,000

Hire purchase & lease creditors

137,000

490,000

1,168,000

2,173,000

6,695,000

Bank overdraft

-

2,067,000

7,533,000

6,096,000

27,743,000

Short term borrowings/Term loans

788,000

1,510,000

2,939,000

3,363,000

195,022,000

Other borrowings

-

-

-

-

17,000,000

Bill & acceptances payable

2,939,000

3,911,000

19,304,000

21,395,000

97,310,000

Provision for taxation

4,826,000

2,424,000

2,763,000

1,740,000

1,723,000

Other liabilities

-

-

6,000,000

6,000,000

-

----------------

----------------

----------------

----------------

----------------

TOTAL CURRENT LIABILITIES

33,449,000

37,807,000

73,734,000

66,029,000

412,128,000

----------------

----------------

----------------

----------------

----------------

NET CURRENT ASSETS/(LIABILITIES)

74,920,000

53,007,000

23,859,000

4,183,000

(271,550,000)

----------------

----------------

----------------

----------------

----------------

TOTAL NET ASSETS

194,263,000

185,873,000

136,442,000

134,969,000

151,958,000

=============

=============

=============

=============

=============

SHARE CAPITAL

Ordinary share capital

76,381,000

76,208,000

76,208,000

76,208,000

76,208,000

----------------

----------------

----------------

----------------

----------------

TOTAL SHARE CAPITAL

76,381,000

76,208,000

76,208,000

76,208,000

76,208,000

RESERVES

Share premium

263,000

90,000

90,000

90,000

90,000

Revaluation reserve

25,545,000

26,167,000

4,708,000

4,668,000

16,485,000

Exchange equalisation/fluctuation reserve

540,000

(1,239,000)

(683,000)

-

299,000

Retained profit/(loss) carried forward

52,036,000

44,718,000

19,459,000

12,350,000

6,313,000

Others

6,404,000

7,067,000

7,004,000

7,004,000

7,004,000

----------------

----------------

----------------

----------------

----------------

TOTAL RESERVES

84,788,000

76,803,000

30,578,000

24,112,000

30,191,000

MINORITY INTEREST

4,988,000

4,680,000

4,485,000

5,180,000

27,449,000

----------------

----------------

----------------

----------------

----------------

SHAREHOLDERS' FUNDS/EQUITY

166,157,000

157,691,000

111,271,000

105,500,000

133,848,000

Long term loans

1,990,000

3,926,000

5,547,000

8,912,000

4,853,000

Lease obligations

152,000

289,000

684,000

1,664,000

612,000

Deferred taxation

11,956,000

13,998,000

11,514,000

11,346,000

11,201,000

Retirement benefits provision

3,214,000

3,902,000

1,385,000

1,199,000

1,444,000

Others

10,794,000

6,067,000

6,041,000

6,348,000

-

----------------

----------------

----------------

----------------

----------------

TOTAL LONG TERM LIABILITIES

28,106,000

28,182,000

25,171,000

29,469,000

18,110,000

----------------

----------------

----------------

----------------

----------------

194,263,000

185,873,000

136,442,000

134,969,000

151,958,000

 

 

 

FINANCIAL RATIO

 

HOVID BERHAD

 

TYPES OF FUNDS

Cash

22,670,000

26,805,000

23,207,000

7,872,000

9,609,000

Net Liquid Funds

19,731,000

20,827,000

(3,630,000)

(19,619,000)

(115,444,000)

Net Liquid Assets

48,426,000

26,670,000

(5,684,000)

(19,505,000)

(354,712,000)

Net Current Assets/(Liabilities)

74,920,000

53,007,000

23,859,000

4,183,000

(271,550,000)

Net Tangible Assets

176,255,000

167,013,000

116,779,000

110,809,000

126,668,000

Net Monetary Assets

20,320,000

(1,512,000)

(30,855,000)

(48,974,000)

(372,822,000)

BALANCE SHEET ITEMS

Total Borrowings

6,006,000

12,193,000

37,175,000

43,603,000

349,235,000

Total Liabilities

61,555,000

65,989,000

98,905,000

95,498,000

430,238,000

Total Assets

227,712,000

223,680,000

210,176,000

200,998,000

564,086,000

Net Assets

194,263,000

185,873,000

136,442,000

134,969,000

151,958,000

Net Assets Backing

166,157,000

157,691,000

111,271,000

105,500,000

133,848,000

Shareholders' Funds

166,157,000

157,691,000

111,271,000

105,500,000

133,848,000

Total Share Capital

76,381,000

76,208,000

76,208,000

76,208,000

76,208,000

Total Reserves

84,788,000

76,803,000

30,578,000

24,112,000

30,191,000

LIQUIDITY (Times)

Cash Ratio

0.68

0.71

0.31

0.12

0.02

Liquid Ratio

2.45

1.71

0.92

0.70

0.14

Current Ratio

3.24

2.40

1.32

1.06

0.34

WORKING CAPITAL CONTROL (Days)

Stock Ratio

53

56

65

56

83

Debtors Ratio

60

63

73

73

40

Creditors Ratio

24

25

30

31

26

SOLVENCY RATIOS (Times)

Gearing Ratio

0.04

0.08

0.33

0.41

2.61

Liabilities Ratio

0.37

0.42

0.89

0.91

3.21

Times Interest Earned Ratio

19.14

11.88

7.97

0.67

(4.58)

Assets Backing Ratio

2.31

2.19

1.53

1.45

1.66

PERFORMANCE RATIO (%)

Operating Profit Margin

13.52

14.94

13.50

(1.42)

(26.75)

Net Profit Margin

9.85

11.44

9.52

(3.94)

(14.49)

Return On Net Assets

13.48

15.14

18.65

3.24

(52.76)

Return On Capital Employed

12.04

13.27

15.03

2.54

(33.52)

Return On Shareholders' Funds/Equity

10.88

12.51

14.09

(5.74)

(39.53)

Dividend Pay Out Ratio (Times)

0.00

0.00

0.55

0.00

0.00

NOTES TO ACCOUNTS

Contingent Liabilities

0

0

0

0

0

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.64.78

UK Pound

1

Rs.99.54

Euro

1

Rs.73.08

 

INFORMATION DETAILS

 

Analysis Done by :

RAS

 

 

Report Prepared by :

NIT

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.